Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gresele

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Minerva Stomatologica|March 1, 1996
[The measurement of PAF (platelet activating factor) in human saliva: standardization of the method]N Staffolani, M Gefrra, E Ribaldi, et al.
Gynecologic and Obstetric Investigation|January 1, 1991
Red cell deformability alterations in normal late pregnancy: possible role of plasma componentsP Tamàs, P Gresele, A Kett, et al.
International Journal of Cardiology|June 23, 2012
Higher levels of plasma matrix metalloproteinase-2 are associated with a significantly increased risk of arterial thrombosis in patients with the antiphospholipid syndromeE Falcinelli, M Pompili, V Pengo, et al.
Thrombosis and Haemostasis|May 9, 2001
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PAM Colucci, A M D'Aprile, A Italia, et al.
Lipids|March 1, 1983
Cholinephosphotransferase activity in human plateletsG Goracci, P Gresele, G Arienti, et al.
Cell Biochemistry and Function|March 1, 1995
Platelet glycohydrolase activities: characterization and releaseC Emiliani, S Martino, A Orlacchio, et al.
European Journal of Clinical Pharmacology|January 1, 1987
In vitro and ex vivo effects of indobufen on red blood cell deformabilityS Grasselli, R Guerciolini, V Iadevaia, et al.
Biochimica Et Biophysica Acta|March 25, 1992
Activation of phospholipase A2 and beta-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulationM Stasi, P Gresele, S Porcellati, et al.
Thrombosis and Haemostasis|March 2, 2011
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutationS Giannini, M Solimando, T Fierro, et al.
Thrombosis Research|May 1, 1992
Thromboxane does not play a significant role in acute, cold-induced vasoconstriction in Raynaud's phenomenon. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonismP Gresele, R Volpato, R Migliacci, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Minerva Stomatologica|March 1, 1996
[The measurement of PAF (platelet activating factor) in human saliva: standardization of the method]N Staffolani, M Gefrra, E Ribaldi, et al.
Gynecologic and Obstetric Investigation|January 1, 1991
Red cell deformability alterations in normal late pregnancy: possible role of plasma componentsP Tamàs, P Gresele, A Kett, et al.
International Journal of Cardiology|June 23, 2012
Higher levels of plasma matrix metalloproteinase-2 are associated with a significantly increased risk of arterial thrombosis in patients with the antiphospholipid syndromeE Falcinelli, M Pompili, V Pengo, et al.
Thrombosis and Haemostasis|May 9, 2001
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PAM Colucci, A M D'Aprile, A Italia, et al.
Lipids|March 1, 1983
Cholinephosphotransferase activity in human plateletsG Goracci, P Gresele, G Arienti, et al.
Cell Biochemistry and Function|March 1, 1995
Platelet glycohydrolase activities: characterization and releaseC Emiliani, S Martino, A Orlacchio, et al.
European Journal of Clinical Pharmacology|January 1, 1987
In vitro and ex vivo effects of indobufen on red blood cell deformabilityS Grasselli, R Guerciolini, V Iadevaia, et al.
Biochimica Et Biophysica Acta|March 25, 1992
Activation of phospholipase A2 and beta-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulationM Stasi, P Gresele, S Porcellati, et al.
Thrombosis and Haemostasis|March 2, 2011
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutationS Giannini, M Solimando, T Fierro, et al.
Thrombosis Research|May 1, 1992
Thromboxane does not play a significant role in acute, cold-induced vasoconstriction in Raynaud's phenomenon. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonismP Gresele, R Volpato, R Migliacci, et al.
Pageof 13